Free Trial

Booz Allen Hamilton (BAH) Competitors

Booz Allen Hamilton logo
$103.89 +0.78 (+0.76%)
Closing price 10/3/2025 03:59 PM Eastern
Extended Trading
$104.08 +0.18 (+0.18%)
As of 10/3/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAH vs. CCRN, CACI, LDOS, SAIC, CTSH, IT, DOX, EPAM, TDC, and HCKT

Should you be buying Booz Allen Hamilton stock or one of its competitors? The main competitors of Booz Allen Hamilton include Cross Country Healthcare (CCRN), CACI International (CACI), Leidos (LDOS), Science Applications International (SAIC), Cognizant Technology Solutions (CTSH), Gartner (IT), Amdocs (DOX), EPAM Systems (EPAM), Teradata (TDC), and The Hackett Group (HCKT).

Booz Allen Hamilton vs. Its Competitors

Booz Allen Hamilton (NYSE:BAH) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

91.8% of Booz Allen Hamilton shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 0.9% of Booz Allen Hamilton shares are held by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Booz Allen Hamilton had 8 more articles in the media than Cross Country Healthcare. MarketBeat recorded 9 mentions for Booz Allen Hamilton and 1 mentions for Cross Country Healthcare. Booz Allen Hamilton's average media sentiment score of 0.99 beat Cross Country Healthcare's score of -0.50 indicating that Booz Allen Hamilton is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Booz Allen Hamilton
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Cross Country Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Booz Allen Hamilton$11.98B1.07$935M$8.1412.76
Cross Country Healthcare$1.34B0.32-$14.56M-$0.26-50.65

Booz Allen Hamilton presently has a consensus price target of $134.00, indicating a potential upside of 28.98%. Cross Country Healthcare has a consensus price target of $17.93, indicating a potential upside of 36.14%. Given Cross Country Healthcare's higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than Booz Allen Hamilton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Booz Allen Hamilton
2 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.23
Cross Country Healthcare
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86

Booz Allen Hamilton has a net margin of 8.70% compared to Cross Country Healthcare's net margin of -0.70%. Booz Allen Hamilton's return on equity of 73.05% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Booz Allen Hamilton8.70% 73.05% 11.61%
Cross Country Healthcare -0.70%1.72%1.24%

Booz Allen Hamilton has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500.

Summary

Booz Allen Hamilton beats Cross Country Healthcare on 14 of the 17 factors compared between the two stocks.

Get Booz Allen Hamilton News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAH vs. The Competition

MetricBooz Allen HamiltonConsulting IndustryBusiness SectorNYSE Exchange
Market Cap$12.82B$6.60B$33.43B$21.82B
Dividend Yield2.11%1.71%2.84%3.54%
P/E Ratio12.7623.2626.7629.82
Price / Sales1.072.94745.5267.04
Price / Cash13.4416.5729.3624.90
Price / Book13.125.518.344.60
Net Income$935M$272.15M$198.07M$1.00B
7 Day Performance4.95%0.68%1.71%2.07%
1 Month Performance1.29%4.01%12.66%3.33%
1 Year Performance-35.39%-8.12%56.94%13.11%

Booz Allen Hamilton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAH
Booz Allen Hamilton
4.9177 of 5 stars
$103.89
+0.8%
$134.00
+29.0%
-35.3%$12.82B$11.98B12.7635,800
CCRN
Cross Country Healthcare
3.3651 of 5 stars
$13.76
-3.3%
$17.93
+30.3%
+7.6%$450.78M$1.34B-52.928,205
CACI
CACI International
3.0442 of 5 stars
$488.05
+0.5%
$549.25
+12.5%
+3.4%$10.73B$8.63B21.8425,000News Coverage
LDOS
Leidos
4.1829 of 5 stars
$185.78
+0.5%
$185.21
-0.3%
+17.6%$23.84B$16.66B17.5648,000Positive News
Analyst Forecast
SAIC
Science Applications International
4.0979 of 5 stars
$97.72
+0.1%
$120.64
+23.5%
-30.2%$4.50B$7.46B16.4826,000Positive News
CTSH
Cognizant Technology Solutions
4.8605 of 5 stars
$67.08
+0.1%
$86.79
+29.4%
-12.3%$32.76B$19.74B13.63336,800Positive News
IT
Gartner
4.8698 of 5 stars
$261.19
-1.1%
$357.44
+36.9%
-49.8%$19.78B$6.30B16.0721,044
DOX
Amdocs
4.9828 of 5 stars
$81.46
-0.2%
$105.33
+29.3%
-6.7%$9.20B$5.00B16.5229,058Ex-Dividend
Analyst Downgrade
EPAM
EPAM Systems
4.9528 of 5 stars
$154.35
+1.7%
$224.06
+45.2%
-22.3%$8.60B$4.73B22.0261,200
TDC
Teradata
3.6878 of 5 stars
$22.13
-0.3%
$26.86
+21.4%
-26.8%$2.09B$1.75B19.585,700Positive News
HCKT
The Hackett Group
4.0146 of 5 stars
$19.04
-1.3%
$29.67
+55.8%
-25.5%$523.79M$313.86M31.731,478

Related Companies and Tools


This page (NYSE:BAH) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners